Contractors / Brigham & Womens Hospital Inc

Brigham & Womens Hospital Inc

prime recipient of federal awards · UEI QN6MS4VN7BD1 ✓ from source

$439.2M

obligated · FY2025

funding agencies

96%

from Health and Hum…

states

100%

in Massachusetts

industries

Obligations by year

≈ computed

$428M

FY23

$410.3M

FY24

$439.2M

FY25

▲ 3%

since FY23

Where this money comes from

✓ from source

FUNDING AGENCIES

BRIGHAM & WOMENS HOSPITA

HHS

$0.4B

6 other agencies

$0B

Brigham & Womens Hospital Inc

$0.4B

FY2025 obligated

band width = obligations · FY2025 · source: USASpending.gov

Biggest awards (total value)

Alliance for Clinical Trials in Oncology Operations Center

awarded 2014$157.1M

Harvard Medical School Vaccine Clinical Trials Unit

awarded 2007$57.1M

Total value over each award’s life, for awards active in FY2025: a decades-long contract can exceed one year’s obligations above.

What it does (NAICS / PSC)

Cardiovascular Diseases Research$74.5M

Allergy and Infectious Diseases Research$52.7M

Aging Research$52M

Trans-NIH Research Support$23.8M

Cancer Treatment Research$23.6M

Arthritis, Musculoskeletal and Skin Diseases Research$17.3M

Military Medical Research and Development$16M

Discovery and Applied Research for Technological Innovations to Improve Human Health$11.8M

Where the work lands

Massachusetts✓ from source$439.2M

Maryland✓ from source$989.3K

Competitors

Lockheed Martin Corporation≈ computed$5.9B

Fluor Marine Propulsion, LLC≈ computed$3.6B

California Institute of Technology≈ computed$2.4B

The Johns Hopkins University Applied Physics Laboratory LLC≈ computed$2B

Fermi Forward Discovery Group, LLC≈ computed$1.7B

Northrop Grumman Systems Corporation≈ computed$1.5B

The Aerospace Corporation≈ computed$1.4B

Booz Allen Hamilton Inc≈ computed$1B

computed from shared NAICS, not a stated rivalry.

Corporate family

Single registration: no combined family.

🔎

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.